It has been a testing time for all of us and although uncertainty clouded our plans, the iGEM competition WILL go ahead, but in a dry lab and online format.
Despite difficulties in recruiting during lock-down, we attracted a staggering 31 applicants. After two days of online interviews, the iGEM supervisors under the leadership of Andrew Dempster, assembled a highly talented, multidisciplinary team of eight, who will hopefully maintain our GOLD medal tradition!
Team Nottingham iGEM 2020 is working on developing an innovative therapeutic to delay the progression of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease. The aim is to engineer the common gut bacterium, Clostridium sporogenes to secrete ketone bodies which will be absorbed into the blood stream and travel to the brain, where they will heal damaged brain tissue and slow down degenerative diseases.
Meet the Team
(Deputy Team Leader)
(Communications and Fundraising Lead)
(Human Practices Lead)
(Recording Officer Lead)
For more information on this year's project see the Nottingham iGEM 2020 Wiki page and to check out what iGEM is all about, visit their website.